Breast Neoplasms (DBCOND0028011)

Identifiers

Synonyms
Neoplasm of the Breast / Neoplasm of Breast / Breast Neoplasm / Neoplasm breast / Breast neoplasm NOS / Neoplasm of breast (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02364960
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)No drug interventionsNot AvailableNot Availableterminated
NCT02229136
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusNo drug interventionssupportive_care2completed
NCT02860104
Ultrasound Guided Percutaneous Microwave Ablation for Breast LesionsNo drug interventionstreatment2 / 3unknown_status
NCT03475433
An Observational Prospective Cohort Study Using an Actigraphy Device.No drug interventionsNot AvailableNot Availablecompleted
NCT04794075
Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT00612443
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation TherapyNo drug interventionssupportive_care2 / 3completed
NCT01910103
Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense BreastsNo drug interventionsNot AvailableNot Availablecompleted
NCT00555503
Registry of Mastectomy for Breast Cancer Risk ReductionNo drug interventionsNot AvailableNot Availablecompleted
NCT00558103
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerNo drug interventionstreatment2completed
NCT00524303
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.No drug interventionstreatment2completed
NCT00422903
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerNo drug interventionstreatment2completed
NCT00173303
The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06380803
Surgical Skill Labs for Robotic Mastectomy and Educational Program Using a Surgical Guide by Artificial IntelligenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT00243503
Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancertreatment2completed
NCT05509790
A Study of LY3484356 in Chinese Participants With Advanced Breast CancerNo drug interventionstreatment1active_not_recruiting
NCT03528590
Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 KilogramsNo drug interventionsotherNot Availableunknown_status
NCT02258464
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT02131064
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNo drug interventionstreatment3completed
NCT01557764
Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast CancerNo drug interventionstreatment2withdrawn
NCT00546364
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT01106521
A Registry Study of Permanent Breast Seed ImplantNo drug interventionstreatmentNot Availablecompleted
NCT01566721
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNo drug interventionstreatment3completed
NCT04886921
Women Underwent TRAM Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic ExercisesNo drug interventionsotherNot Availablecompleted
NCT04065321
Circulating Tumor Cell Detection in Patients With Luminal A Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05887102
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT00148902
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)treatment1completed
NCT02850302
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PETNo drug interventionsdiagnosticNot Availablecompleted
NCT04568902
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerNo drug interventionstreatment1active_not_recruiting
NCT02229084
Vaccination of High Risk Breast Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT03283384
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.No drug interventionstreatment2active_not_recruiting
NCT00485979
Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer PatientsNo drug interventionstreatment2completed
NCT04343079
Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT01302379
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT02744079
Comparison of Healthy Diets on Breast Cancer MarkersNo drug interventionsotherNot Availablecompleted
NCT02580279
Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant RadiotherapyNo drug interventionstreatment2unknown_status
NCT01042379
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerNo drug interventionstreatment2recruiting
NCT00174343
Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patientstreatment2completed
NCT00187343
A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT)No drug interventionstreatment3completed
NCT00966043
Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising EnzymesNo drug interventionsNot AvailableNot Availablecompleted
NCT00386087
Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyNo drug interventionstreatment2completed
NCT03532087
Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancerbasic_science2withdrawn
NCT00201487
Choline Quantification in Breast Cancer by MRSNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumorstreatment1completed
NCT00211133
A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapytreatment3completed
NCT00083733
Genetic and Protein Profiling in Normal and Cancerous Breast TissueNo drug interventionsNot AvailableNot Availablecompleted
NCT00048633
Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancertreatment2completed
NCT00169533
Rollover Study Of Lapatinib In Cancer Patientstreatment1completed
NCT05949333
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapytreatment4recruiting
NCT00319254
Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast CancerNo drug interventionstreatment2completed
NCT03343054
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumorstreatment1completed
NCT05514054
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancertreatment3recruiting
NCT04119154
Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)No drug interventionsdiagnosticNot Availablecompleted
NCT00575354
Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor ExcisionNo drug interventionstreatment4completed
NCT00821054
A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer PatientsNo drug interventionsother1completed
NCT04142554
Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancerbasic_science1withdrawn
NCT00062751
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasmstreatment2completed
NCT00051051
A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancertreatment2completed
NCT03242551
Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast CancerNo drug interventionstreatment2unknown_status
NCT05113251
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancertreatment3active_not_recruiting
NCT02258451
Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancertreatment2completed
NCT00682253
Use of Bone Scintigraphy, CT and MRI in Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03791853
Light-CT in the Diagnosis of Breast Tumor and Lymph NodeNo drug interventionsNot AvailableNot Availableunknown_status
NCT00267553
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancertreatment3terminated
NCT02309177
Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancertreatment1completed
NCT02549677
Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancertreatment4completed
NCT01670877
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancertreatment2completed
NCT02518477
Preventive Intervention Against Lymphedema After Breast Cancer SurgeryNo drug interventionspreventionNot Availablecompleted
NCT00385177
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03796845
Limited Versus No-limited Shoulder Movement in Breast Cancer SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT02547545
Breast Cancer Chemotherapy Risk Prediction Mathematical ModelNo drug interventionsNot AvailableNot Availableunknown_status
NCT01953445
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancertreatment2withdrawn
NCT06052345
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06480045
Usage Of Artificial Intelligence-Integrated Usg In Application of Pectoral Block In MastectomiesNo drug interventionsotherNot Availablecompleted
NCT01239745
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast CancerNot AvailableNot Availableterminated
NCT00519545
Prayer as a Possible Adjuvant Treatment for Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01864798
A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancertreatment2terminated
NCT00166998
The Study of Infrared Imaging on Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00263198
PTK and Letrozole in Post-menopausal Women With Advanced Breast CancerNo drug interventionstreatment2terminated
NCT00001498
A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancertreatment2completed
NCT03277898
Aerobic Exercise and Cognitive Functioning in Women With Breast CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04239105
Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum DeviceNo drug interventionsNot AvailableNot Availableunknown_status
NCT01435005
Breast Cancer and Exercise Trial in AlbertaNo drug interventionspreventionNot Availablecompleted
NCT05036005
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)treatment4recruiting
NCT05398497
FreezIng bReaST Cancer in Brazil: a Before-after StudyNo drug interventionstreatmentNot Availableunknown_status
NCT03094897
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer DiagnosticsNo drug interventionsdiagnostic0unknown_status
NCT00246597
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancertreatment3terminated
NCT04822597
Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracersupportive_care3completed
NCT00071383
Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2No drug interventionsNot AvailableNot Availablecompleted
NCT03929783
Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast FindingsNo drug interventionsdiagnosticNot Availablecompleted
NCT04014283
Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.No drug interventionspreventionNot Availableactive_not_recruiting
NCT01086683
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation CourseNo drug interventionssupportive_care2 / 3completed
NCT06043661
Early Detection of Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02473861
EXercise Influence on Taxane Side Effects (EXIT) StudyNo drug interventionssupportive_careNot Availablecompleted
NCT02650661
Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyNo drug interventionssupportive_careNot Availablecompleted
NCT00210028
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancertreatment2terminated
NCT00281528
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancertreatment2terminated
NCT02271828
Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT01220128
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancertreatment2terminated
NCT00584428
High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT03379428
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancertreatment1 / 2active_not_recruiting
NCT00073528
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancertreatment3completed
NCT04177628
Shared Decision Making With Breast Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00263211
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patientstreatment2terminated
NCT01476111
Evaluation of Specific Biomarkers in Primary Invasive Breast CancerNo drug interventionsNot AvailableNot Availableterminated
NCT03025711
Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab EmtansineNo drug interventionsNot AvailableNot Availablecompleted
NCT00001193
A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast CancerNo drug interventionstreatment2completed
NCT05573893
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanNo drug interventionsNot AvailableNot Availablerecruiting
NCT00048893
Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancertreatment1 / 2terminated
NCT00190593
Raloxifene Use for The Heartprevention3completed
NCT02657993
Hypnosis to Reduce Aromatase Inhibitor Pain and Improve AdherenceNo drug interventionstreatmentNot Availablecompleted
NCT01217593
Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast SurgeryNo drug interventionssupportive_careNot Availableunknown_status
NCT04052893
DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the BreastNo drug interventionstreatmentNot Availablerecruiting
NCT01978171
Prediction of Everolimus-induced Interstitial Lung DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01447771
Decision Support for Women With Breast CancerNo drug interventionssupportive_careNot Availableterminated
NCT02151071
The Breast Surgery EnLight and LightPath Imaging System StudyNo drug interventionsdiagnostic1 / 2unknown_status
NCT01740271
A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patientstreatment2recruiting
NCT00128778
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patientstreatment4completed
NCT01801878
Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated BreastsNo drug interventionssupportive_careNot Availablewithdrawn
NCT02171078
Post-Treatment Surveillance in Breast Cancer: Bringing CER to the AllianceNo drug interventionsNot AvailableNot Availablecompleted
NCT05603078
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)No drug interventionstreatmentNot Availablerecruiting
NCT00774878
Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast CancerNo drug interventionstreatment2terminated
NCT06234488
Multi-Institutional Transgender & Gender-Diverse Breast Cancer StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00403988
Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast CarcinomaNo drug interventionstreatment2terminated
NCT03461588
Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT00263588
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancertreatment2completed
NCT00184288
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.No drug interventionsNot AvailableNot Availablewithdrawn
NCT04488107
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437ctreatment1 / 2unknown_status
NCT00174707
Study of Docetaxel in Breast Cancer Patientstreatment3completed
NCT04711109
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutationprevention3recruiting
NCT00435409
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerNo drug interventionstreatment3completed
NCT02581709
An Intervention Programme to Reduce Cognitive Impairment Due to CancerNo drug interventionssupportive_careNot Availableterminated
NCT01344109
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00373256
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerNo drug interventionstreatment3completed
NCT01395056
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00689156
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerNo drug interventionstreatment3completed
NCT00479856
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast CancerNo drug interventionstreatment2terminated
NCT05675085
Risk-Based Breast Screening in Young WomenNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT00386685
XRP9881 in Combination With Trastuzumab in Metastatic Breast CancerNo drug interventionstreatment2completed
NCT02218385
ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate FluidNo drug interventionsNot AvailableNot Availablecompleted
NCT02720185
Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRbasic_science2terminated
NCT00243685
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for ApoptosisNo drug interventionstreatment2 / 3completed
NCT06421285
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02934815
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT02823015
Acute Pain Trajectories and Persistent Pain After Breast Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02011815
Exploring Biological Linkage Between Circadian Disruption and Cancer ProgressionNo drug interventionsNot AvailableNot Availablecompleted
NCT01151215
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancertreatment2terminated
NCT02239315
Study of Tumor RNA Disruption Assay™ (RDA)No drug interventionsdiagnosticNot Availableterminated
NCT06475937
A Study of DM001 in Patients With Advanced Solid TumorsNo drug interventionstreatment1not_yet_recruiting
NCT06407037
Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane BlockNo drug interventionstreatmentNot Availablerecruiting
NCT02512237
A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expressiontreatment1terminated
NCT02494037
The Canadian/US Integrative Oncology StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00973037
CYP2D6 Genotype on the Clinical Effect of TamoxifenNot AvailableNot Availableunknown_status
NCT06566937
The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer PatientsNo drug interventionspreventionNot Availablerecruiting
NCT03329937
Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancertreatment1completed
NCT05285332
Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant TherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04752332
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancertreatment3terminated
NCT05463952
A Study to Learn About the ARV-471 (PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)treatment1active_not_recruiting
NCT02931552
Nuevo Amanecer II: Translating a Stress Management Program for LatinasNo drug interventionssupportive_careNot Availablecompleted
NCT01257152
Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00360152
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph NodesNo drug interventionsdiagnostic0completed
NCT02954900
Know Your Risk: Assessment at Screening for Breast Cancer - Pilot StudyNo drug interventionspreventionNot Availablecompleted
NCT00620100
To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentNo drug interventionstreatment2terminated
NCT00471159
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.No drug interventionstreatment2withdrawn
NCT00807859
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerNo drug interventionstreatment1completed
NCT05181059
DLSCT for Breast Cancer Detection in Women With Dense BreastsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02655159
Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availableterminated
NCT00722059
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital MammographyNo drug interventionsdiagnostic0completed
NCT02652975
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional EndotheliumNo drug interventionspreventionNot Availablecompleted
NCT03685175
Using Hyperpolarized [1-13C]Pyruvate to Detect CardiotoxicityNo drug interventionsdiagnostic0enrolling_by_invitation
NCT04677075
New Formula to Predict the Need for Reconstructive Coverage Following MastectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01735175
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®supportive_care3completed
NCT00184275
Characterization of Brain MetastasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04771975
Connecting Breast Cancer Survivors for ExerciseNo drug interventionssupportive_careNot Availablecompleted
NCT03105570
The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort StudyNo drug interventionstreatmentNot Availablerecruiting
NCT00063570
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapytreatment2completed
NCT00736970
Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)No drug interventionstreatment2completed
NCT00075270
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancertreatment3completed
NCT06121570
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancertreatment1recruiting
NCT03762642
Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04892342
Study of ESG401 in Adults With Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT06180642
Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT01122342
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.treatment1 / 2suspended
NCT05004142
Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelintreatment2unknown_status
NCT00919399
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvanttreatment2completed
NCT05430399
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancertreatment3recruiting
NCT00393406
The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method ApproachNo drug interventionsNot AvailableNot Availablecompleted
NCT02892006
LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With CancerNo drug interventionsotherNot Availablecompleted
NCT02557906
Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)No drug interventionstreatmentNot Availableunknown_status
NCT02751606
Nano MRI on 7 Tesla in Rectal and Breast CancerNo drug interventionsdiagnostic3unknown_status
NCT01953536
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)treatment2withdrawn
NCT01298713
Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancertreatment2completed
NCT06464913
Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic ReconstructionNo drug interventionstreatment2recruiting
NCT01043913
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueNo drug interventionstreatment2completed
NCT00115713
Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During ChemotherapyNo drug interventionstreatment3completed
NCT05452213
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patientstreatment4recruiting
NCT05566613
Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02686918
Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice NurseNo drug interventionssupportive_careNot Availableunknown_status
NCT00034918
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancertreatment2completed
NCT00709618
Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer SubjectsNo drug interventionstreatment2terminated
NCT01279018
Persistent Pain After Breast Cancer Treatment With DocetaxelNo drug interventionsNot AvailableNot Availablecompleted
NCT05172518
Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancertreatment3not_yet_recruiting
NCT00925418
Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerNo drug interventionsprevention3completed
NCT02162719
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptorstreatment2completed
NCT03280719
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 FractionsNo drug interventionstreatmentNot Availablecompleted
NCT00245219
Understanding Shared Psychobiological PathwaysNo drug interventionstreatmentNot Availablecompleted
NCT03583619
Randomized Trial of Accelerated Partial Breast IrradiationNo drug interventionstreatmentNot Availablecompleted
NCT00080041
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumorstreatment1completed
NCT03393741
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor BiopsyNot AvailableNot Availableterminated
NCT00035841
Phase 2 Study of TLK286 in Metastatic Breast Cancertreatment2completed
NCT05558917
Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast SurgeryNo drug interventionssupportive_careNot Availableunknown_status
NCT00353717
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast CarcinomaNo drug interventionstreatment1 / 2unknown_status
NCT04531917
The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer SurvivorsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03434717
Optimized Rehabilitation Following Primary Breast Cancer SurgeryNo drug interventionssupportive_careNot Availablerecruiting
NCT00150917
RCT of a Group Intervention for Women With a Family History of Breast CancerNo drug interventionsprevention3completed
NCT02776917
Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancertreatment1completed
NCT00322517
Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast CancerNo drug interventionstreatment2completed
NCT05814224
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNANo drug interventionsotherNot Availablerecruiting
NCT00611624
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT01118624
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancertreatment2completed
NCT00076024
AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancertreatment1 / 2completed
NCT02817724
Integral Strategy to Supportive Care in Breast Cancer PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT00820924
Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsNo drug interventionstreatment2terminated
NCT05346224
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancertreatment3active_not_recruiting
NCT05807516
Single-cell RNAseq Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00790816
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer AgentsNo drug interventionstreatment1completed
NCT04707196
A Study of Abemaciclib in Indian Women With Advanced Breast Cancertreatment4completed
NCT02887196
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer TreatmentNo drug interventionsNot AvailableNot Availableterminated
NCT00600496
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)No drug interventionstreatment1active_not_recruiting
NCT00473096
Efficacy Study of an Educational Program for Decision Support for Breast CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT05700396
Breast Cancer Survivor Educational InterventionNo drug interventionssupportive_careNot Availablerecruiting
NCT04334096
Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and TherapyNo drug interventionstreatmentNot Availablecompleted
NCT01441596
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastasestreatment2completed
NCT00372996
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast CancerNo drug interventionstreatment2terminated
NCT01281696
Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasistreatment2completed
NCT00351858
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT03556358
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancertreatment3completed
NCT04895358
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)treatment3active_not_recruiting
NCT00444535
Lapatinib and Bevacizumab for Metastatic Breast CancerNo drug interventionstreatment2completed
NCT00616135
Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After LumpectomyNo drug interventionstreatment4completed
NCT02637635
Does Autologous Fat Transplantation Improve Results and Reduce Complications in Breast Reconstruction With Implants?No drug interventionstreatmentNot Availableunknown_status
NCT03381963
Hemostatic Profiles of Endocrine Therapies for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03280563
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancertreatment1 / 2active_not_recruiting
NCT06313463
Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapytreatment3recruiting
NCT00579163
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01140763
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03153163
Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast Cancertreatment1completed
NCT00062686
GW572016 For Treatment Of Refractory Metastatic Breast Cancertreatment2completed
NCT04777786
Early Rehabilitation for Breast Cancer - A Randomized Control TrialNo drug interventionstreatmentNot Availableterminated
NCT02389686
Intra-operative Radiotherapy For Breast Cancer Women After NSMNo drug interventionstreatmentNot Availablerecruiting
NCT01959386
A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast CancerNot AvailableNot Availablecompleted
NCT03257839
Delphinus SoftVue Prospective Case Collection - ARM 1No drug interventionsNot AvailableNot Availablecompleted
NCT00393939
Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast CancerNo drug interventionstreatment3completed
NCT00490139
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNo drug interventionstreatment3completed
NCT04824339
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.No drug interventionstreatmentNot Availableunknown_status
NCT05367739
Real World Study on the Efficacy and Safety of Anti-HER2 TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01786122
Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT03144622
18F-FSPG PET/CT Imaging in Patients With CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT00783822
Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00197522
Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2No drug interventionstreatment1completed
NCT00374322
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNo drug interventionstreatment3completed
NCT01763125
Establishment of a Tumor Bank for Blood SamplesNo drug interventionsNot AvailableNot Availablerecruiting
NCT01042925
Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimentreatment1 / 2completed
NCT00268125
Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.No drug interventionsprevention3completed
NCT00426530
Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerNo drug interventionstreatment1completed
NCT01164930
Impact of Acceptance and Commitment Therapy on Early Stage Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05402930
Angiomammography and Neoadjuvant ChemotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT01095848
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerNo drug interventionstreatment1completed
NCT00279448
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerNo drug interventionstreatment3completed
NCT02876848
A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)No drug interventionssupportive_careNot Availableunknown_status
NCT00301548
Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast CancerNo drug interventionstreatment2completed
NCT04982848
Korea Post Marketing Surveillance (PMS) Study of Talzenna®Not AvailableNot Availablenot_yet_recruiting
NCT05978648
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapytreatment2recruiting
NCT06376357
The Effect of Foot Massage With Roles on Cancer PatientsNo drug interventionssupportive_careNot Availableenrolling_by_invitation
NCT00418457
Regional Anesthesia and Breast Cancer RecurrenceNo drug interventionsprevention3completed
NCT06121557
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancertreatment1recruiting
NCT00071357
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04852926
Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.No drug interventionsNot AvailableNot Availablerecruiting
NCT02613026
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancertreatment3completed
NCT00035126
EPO906 Therapy in Patients With Advanced Breast Cancertreatment2completed
NCT02013726
MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast TissueNo drug interventionsdiagnosticNot Availablewithdrawn
NCT03669926
The Tomosynthesis Trial in Bergen - Part 2No drug interventionsdiagnosticNot Availablecompleted
NCT01125566
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatmenttreatment3completed
NCT05253066
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancertreatment2 / 3not_yet_recruiting
NCT04803266
Elective Internal Mammary Node Irradiation in Women With Node-positive Breast CancerNo drug interventionstreatment3unknown_status
NCT03787966
Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise ProgramNo drug interventionstreatmentNot Availablerecruiting
NCT01401166
Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancerhealth_services_research2completed
NCT01875666
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinibdiagnostic0completed
NCT06207474
A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)No drug interventionsotherNot Availablecompleted
NCT03099174
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancertreatment1completed
NCT01383174
Nuevo Amanecer: Promoting the Psychosocial Health of LatinasNo drug interventionssupportive_careNot Availablecompleted
NCT00508274
Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From ChinaNo drug interventionstreatment3terminated
NCT04585074
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01653574
A Study of Famitinib Malate in HER2-negative Metastatic Breast CancerNo drug interventionstreatment2completed
NCT01609920
Nodal Staging in Breast Cancer With MRLdiagnosticNot Availableterminated
NCT02341820
PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - LongitudinalNo drug interventionsNot AvailableNot Availablecompleted
NCT04796220
Focused Ultrasound and Gemcitabine in Breast Cancertreatment1recruiting
NCT00302120
The MONET - Study: MR Mammography of Nonpalpable Breast TumorsNo drug interventionsdiagnostic4unknown_status
NCT02681120
Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02765620
PERCIST Criteria for Response Evaluation With Solid TumorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02819882
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)No drug interventionsNot AvailableNot Availablerecruiting
NCT05600582
A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast CancerNo drug interventionstreatment1withdrawn
NCT02831582
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02112682
Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a MastectomyNo drug interventionstreatmentNot Availableterminated
NCT00716482
Ultrasound Elastography of Breast LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT02035631
Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity InterventionNo drug interventionsprevention3unknown_status
NCT00661531
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyNo drug interventionstreatment2terminated
NCT01904331
Breast Cancer Long-term Outcome of Cardiac DysfunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT00437073
Brain Metastases In ErbB2-Positive Breast CancerNo drug interventionstreatment2terminated
NCT02389673
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00900627
Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)treatment1 / 2completed
NCT00046527
Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancertreatment3completed
NCT00419627
Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and PancreasNo drug interventionsNot AvailableNot Availableunknown_status
NCT00050427
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancertreatment2completed
NCT02898727
A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT03039127
Immunostimulating Interstitial Laser Thermotherapy in Breast CancerNo drug interventionstreatmentNot Availableterminated
NCT02307227
Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumorstreatment2completed
NCT01757327
LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancertreatment2withdrawn
NCT00388076
Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)No drug interventionstreatment1completed
NCT00471276
Efficacy And Safety Of Sunitinib In Women With Advanced Breast CancerNo drug interventionstreatment2completed
NCT01658176
Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancertreatment2withdrawn
NCT05257876
Breathing Exercise for Chronic Pain Management in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03250676
Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast CancerNo drug interventionstreatment1 / 2completed
NCT06026176
Pattern of Clinical Presentation of Different Breast Disease in Surgical Opd at BPKIHSNo drug interventionsNot AvailableNot Availablecompleted
NCT06140576
The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.treatment1 / 2not_yet_recruiting
NCT01097460
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancertreatment1completed
NCT01948960
Influence of Exceptional Patient Characteristics on Everolimus Exposurediagnostic4completed
NCT03471494
GlobalSurg 3: Quality and Outcomes in Global Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05274594
Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01815294
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancertreatment1completed
NCT00746694
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)No drug interventionsNot AvailableNot Availablecompleted
NCT04767594
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.Not AvailableNot Availablerecruiting
NCT02740491
Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00044291
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancertreatment3completed
NCT04228991
Hypofractionated LocoRegional Radiotherapy in Breast CancerNo drug interventionstreatment3recruiting
NCT00067691
Acupuncture for Shortness of Breath in Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT04832191
CE-MRI&CESM in Solid Breast LesionsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04109391
Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03treatment3completed
NCT03202862
The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancertreatment2unknown_status
NCT06379880
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring SolutionNo drug interventionspreventionNot Availablerecruiting
NCT03304080
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breasttreatment1 / 2active_not_recruiting
NCT02690480
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancertreatment2unknown_status
NCT01789229
Establishment of a Tumor Bank for Tissue SamplesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00543829
German Preoperative Adriamycin Docetaxel StudyNo drug interventionstreatment2completed
NCT03705429
A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancerother3completed
NCT01524029
Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT02809729
Antibiotic Prophylaxis in Oncological Surgery of BreastpreventionNot Availablecompleted
NCT00849329
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerNo drug interventionstreatment1completed
NCT02913729
Pre- Versus Postoperative Accelerated Partial Breast IrradiationNo drug interventionstreatmentNot Availableterminated
NCT02952989
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumorstreatment1terminated
NCT04288089
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast CancerNo drug interventionstreatment1active_not_recruiting
NCT04544189
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT02364492
A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of RelapseNo drug interventionstreatment1completed
NCT01905592
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsNo drug interventionstreatment3terminated
NCT00341692
Studying Normal Breast Tissue and Cancer RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT01167192
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerNo drug interventionstreatment2terminated
NCT06062992
Contrast-Enhanced Stereotactic BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04023292
Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancertreatment2recruiting
NCT04722692
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in SituNo drug interventionstreatment3recruiting
NCT00121992
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatmenttreatment3completed
NCT02611544
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01961544
Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast CancerNo drug interventionstreatment4completed
NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancertreatment3terminated
NCT03583944
A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast CancerNo drug interventionstreatment4completed
NCT03791840
The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADSNo drug interventionsNot AvailableNot Availablecompleted
NCT05904340
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated With Chemotherapy Induced Peripheral NeuropathyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05328440
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)No drug interventionstreatment2recruiting
NCT05812040
Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple DischargeNo drug interventionsdiagnosticNot Availablerecruiting
NCT03200067
Effects on the Personalized Rehabilitation Service in Patients With CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT02864667
Reader Study for Image Quality of Cone Beam Breast CT SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT00431067
Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab TherapyNo drug interventionstreatment2completed
NCT00038467
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancertreatment3completed
NCT01272401
Quality of Life in Breast Cancer Patients and SurvivorsNo drug interventionsNot AvailableNot Availablecompleted
NCT05981001
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast CancerNo drug interventionstreatment1 / 2recruiting
NCT02484404
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...No drug interventionstreatment1 / 2recruiting
NCT00291304
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast CarcinomaNo drug interventionsother2terminated
NCT05642104
The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04123704
Sitravatinib in Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT05607004
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNo drug interventionstreatment2recruiting
NCT03785704
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast CancerNo drug interventionstreatment2recruiting
NCT05782504
Patient-centered Breast Cancer TeleprehabilitationNo drug interventionstreatmentNot Availablerecruiting
NCT06061172
Digital Tool Enhancing GPs' Information Management for Patients With Multimorbidity - a Pilot StudyNo drug interventionstreatmentNot Availablerecruiting
NCT00146172
Study Evaluating HKI-272 in Tumorstreatment1completed
NCT05443672
Multi-center Study of Deep Learning AI in Breast MassNo drug interventionsNot AvailableNot Availableunknown_status
NCT00617968
GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerNo drug interventionstreatment2completed
NCT00043368
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)treatment2completed
NCT05946668
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00052169
Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancertreatment2completed
NCT02403869
Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line MonochemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00390169
Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer PatientsNo drug interventionsNot Available3unknown_status
NCT00270569
An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancertreatment2unknown_status
NCT04880369
Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene ExpressionNo drug interventionspreventionNot Availablewithdrawn
NCT03709446
Leflunomide in Previously Treated Metastatic Triple Negative CancersNo drug interventionstreatment1 / 2recruiting
NCT02575612
Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00580112
An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerNo drug interventionstreatment2completed
NCT06517212
Tirzepatide in Patients With Obesity or Overweight Who Have High Risk Early Breast Cancer and Are ctDNA+No drug interventionstreatment2not_yet_recruiting
NCT00732810
SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)No drug interventionstreatment2completed
NCT02825810
Cervical Motor Control in Long-term Breast Cancer SurvivorsNo drug interventionstreatmentNot Availablewithdrawn
NCT04927910
Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast CancerNo drug interventionssupportive_care2terminated
NCT00324610
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenNo drug interventionsNot Available1 / 2unknown_status
NCT05054010
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy ParticipantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00650910
Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast CancerNo drug interventionstreatment1completed
NCT01273610
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT00184210
Magnetic Resonance (MR) Spectroscopy of Breast Cancer TissueNo drug interventionsNot AvailableNot Availableterminated
NCT02226081
ShearWave™ Elastography of Breast Lesions in Chinese PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05214781
The Significance of Radiologically Detected Intramammary Lymph Nodes in Prediction of Axillary Lymph Nodes Status in Breast Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00356681
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerNo drug interventionstreatment2terminated
NCT00355381
Evaluating Patient Information PrescriptionsNo drug interventionstreatment2completed
NCT05494281
Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast CancerNo drug interventionspreventionNot Availableunknown_status
NCT03270995
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00102895
A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancertreatment2terminated
NCT02719795
Pectoral Nerves Blocks for Chronic PainNo drug interventionstreatment0unknown_status
NCT03295695
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer PatientNo drug interventionssupportive_care0withdrawn
NCT00046514
ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancertreatment2completed
NCT00067314
Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapytreatment2completed
NCT00708214
BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast CancerNo drug interventionstreatment2completed
NCT06125314
HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation CouncilNo drug interventionsNot AvailableNot Availablerecruiting
NCT00646555
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With AngiogenesisNo drug interventionsNot AvailableNot Availablecompleted
NCT02781155
Limiting Chemotherapy Side Effects by Using MoxaNo drug interventionssupportive_care1 / 2unknown_status
NCT00021255
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancertreatment3completed
NCT01626950
Living Conditions and Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00258050
To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patientstreatment1completed
NCT01773850
Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT06234150
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive ImpairmentNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00105950
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancertreatment2completed
NCT00036023
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignanciestreatment2completed
NCT02320123
End-of-Life Care for African AmericansNo drug interventionshealth_services_researchNot Availablecompleted
NCT02279108
Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast CancerNo drug interventionsdiagnostic3completed
NCT03742908
Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction PatientsNo drug interventionspreventionNot Availableunknown_status
NCT01623908
Bone Loss Treatment From Adjuvant Zoledronate EfficacyNo drug interventionstreatmentNot Availableterminated
NCT04975308
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerNo drug interventionstreatment3active_not_recruiting
NCT06105008
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast CancerNo drug interventionstreatment2withdrawn
NCT00300508
3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancertreatment3completed
NCT00976508
Figitumumab Combined With Pegvisomant For Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT03367208
Study of Metabolites Markers in Adjuvant Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00155038
Imaging Characteristics of Breast Cancer in Women Under 40 Years of AgeNo drug interventionsNot AvailableNot Availableunknown_status
NCT02548338
Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast CancerNo drug interventionstreatment2 / 3completed
NCT00001338
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast CancerNo drug interventionstreatment3completed
NCT06327438
Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control TrialNo drug interventionstreatmentNot Availablerecruiting
NCT01276938
Exclusive Intraoperative Radiation Therapy for Breast CancerNo drug interventionstreatment2 / 3completed
NCT00832338
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresNo drug interventionstreatment2terminated
NCT04117438
Tell us Your Food StoryNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02297438
A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]No drug interventionstreatment3active_not_recruiting
NCT05146843
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT00583843
Ultrasound Targeting for the Lumpectomy CavityNo drug interventionsNot AvailableNot Availablecompleted
NCT01679743
GRN1005 for Brain Metastases From Breast or Lung CancerNo drug interventionsdiagnostic2withdrawn
NCT05401643
Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT01669343
Aromatase Inhibitor Host Factors StudyNo drug interventionstreatmentNot Availablecompleted
NCT05327543
Effects of Yoga on the Quality of Life of Breast Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT00145743
Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast CancerNo drug interventionstreatment1 / 2completed
NCT02107703
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast CancerNo drug interventionstreatment3active_not_recruiting
NCT00038103
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifentreatment2completed
NCT00242203
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancertreatment2completed
NCT04059003
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00051103
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.No drug interventionstreatment2completed
NCT03756090
The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02400190
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)No drug interventionstreatmentNot Availableactive_not_recruiting
NCT00649090
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerNo drug interventionstreatment4completed
NCT00359190
Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast CancerNo drug interventionstreatment1completed
NCT05478590
A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data SettingNo drug interventionsNot AvailableNot Availablecompleted
NCT00155090
Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women VolunteersNo drug interventionsNot AvailableNot Availableunknown_status
NCT00143390
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancertreatment3completed
NCT01975064
Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaNo drug interventionssupportive_care4completed
NCT00477464
Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerNo drug interventionstreatment2completed
NCT02950064
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsNo drug interventionstreatment1unknown_status
NCT02948764
Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02872064
Treatment of Primary Breast Cancer Using PDTNo drug interventionstreatmentNot Availablecompleted
NCT05382364
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)No drug interventionstreatment1active_not_recruiting
NCT02982564
Effect of Low vs Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02756364
Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor TherapyNo drug interventionstreatment2completed
NCT02689921
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast CancerNo drug interventionstreatment2unknown_status
NCT04983121
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer PatientsNo drug interventionstreatment2recruiting
NCT00097721
A Study of E7389 in Advanced/Metastatic Breast Cancer Patientstreatment2completed
NCT02852421
Single Versus Multiple Injection Ultrasound Guided Paravertebral BlocksNo drug interventionstreatmentNot Availablecompleted
NCT02819921
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenNo drug interventionstreatment4terminated
NCT05243121
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04783402
Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.No drug interventionstreatmentNot Availableenrolling_by_invitation
NCT00178802
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian CancersNo drug interventionstreatment2unknown_status
NCT05494502
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer PatientsNo drug interventionspreventionNot Availablerecruiting
NCT02529384
Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast LesionsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05232084
Different Volumes of Erector Spinae Plane Block for Breast SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT03881384
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00001384
A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patientstreatment2completed
NCT02043184
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRNo drug interventionssupportive_careNot Availablecompleted
NCT00419679
Use of Hair to Diagnose Breast CancerNo drug interventionsdiagnostic1 / 2unknown_status
NCT00051779
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast CancerNo drug interventionstreatment1completed
NCT01917279
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCNo drug interventionstreatment3unknown_status
NCT04562987
The Patterns of Activity and Cognition During Treatment (PACT) StudyNo drug interventionssupportive_careNot Availablecompleted
NCT01299987
Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients With Small Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT06024187
Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled TrialNo drug interventionstreatmentNot Availablerecruiting
NCT00272987
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinibtreatment3terminated
NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesNo drug interventionstreatment1recruiting
NCT00111787
Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancertreatment2completed
NCT00904033
Calcitriol, Physical Activity, and Bone Health in Cancer SurvivorsNo drug interventionsprevention2completed
NCT05403333
Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast CancerNo drug interventionstreatment2not_yet_recruiting
NCT02077933
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsNo drug interventionstreatment1completed
NCT02057133
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadNo drug interventionstreatment1active_not_recruiting
NCT00251433
GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerNo drug interventionstreatment1terminated
NCT03586154
Combined Intra-articular Shoulder Injection and Stellate Ganglion Block in Chronic Post-mastectomy Shoulder PainNo drug interventionstreatment4completed
NCT04730154
PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCSNo drug interventionstreatmentNot Availablerecruiting
NCT00425854
An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast CancerNo drug interventionsdiagnostic2completed
NCT01782651
Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04586751
The Impact of Pecs Blocks on Postmastectomy Pain SyndromeNo drug interventionspreventionNot Availablecompleted
NCT01338753
Study to Evaluate Markers of Response in Locally Advanced Breast CancerNo drug interventionsdiagnostic2completed
NCT06567353
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02030353
The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT01431053
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast CancerNo drug interventionsprevention2unknown_status
NCT01284153
Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01384253
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyNo drug interventionstreatment1completed
NCT05764577
DIEP Flap Surgery and Intraabdominal PressureNo drug interventionsNot AvailableNot Availablecompleted
NCT03272477
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsNo drug interventionstreatment2completed
NCT00291577
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancertreatment1completed
NCT02977247
Delphinus SoftVue Prospective Case Collection - ARM 2No drug interventionsNot AvailableNot Availablecompleted
NCT04364347
Chemotherapy-induced Circadian Rhythm DisruptionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02151747
Testing BRCA 1/2 Mutation Using Next Generation SequencingNo drug interventionsNot AvailableNot Availablecompleted
NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyNo drug interventionstreatment2active_not_recruiting
NCT02479347
Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodineNo drug interventionsprevention4completed
NCT00338247
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNo drug interventionsNot AvailableNot Availableapproved_for_marketing
NCT06443645
Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-BNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05797545
Comparison of Ultrasound and Breast MRI for Breast Cancer DetectionNo drug interventionsscreeningNot Availablerecruiting
NCT06096545
Axillary Management After Neoadjuvant ChemotherapyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02032745
Genomic Signatures to Predict Treatment ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT00325598
Partial Breast Irradiation (PBI) for Selected Patients With Early Breast CancerNo drug interventionstreatment1 / 2completed
NCT02959398
Evaluation of Tomosynthesis for Characterization and the Management of Breast LesionsNo drug interventionsdiagnosticNot Availableunknown_status
NCT00637598
Early Detection of Breast Cancer Using Tomosynthesis ImagingNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT04934098
Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related LymphedemaNo drug interventionstreatmentNot Availablerecruiting
NCT05689398
Rehabilitation on Equal Terms - The ReMig StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02254005
Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast CancerNo drug interventionstreatment1completed
NCT00973505
CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)No drug interventionsNot AvailableNot Availableunknown_status
NCT00448305
EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsNo drug interventionstreatment2completed
NCT02781805
Pilot Study of Bisphosphonates for Breast CancerNo drug interventionsprevention1terminated
NCT00001805
A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximabtreatment2completed
NCT05385705
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020No drug interventionstreatment1recruiting
NCT00593697
The Synergism Or Long Duration (SOLD) StudyNo drug interventionstreatment3completed
NCT05072197
Mobile Application Support for Women With Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT02946697
A Culturally Sensitive Social Support InterventionNo drug interventionssupportive_careNot Availablerecruiting
NCT04858997
Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese PatientsNo drug interventionstreatment2unknown_status
NCT00080197
Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patientstreatment2completed
NCT04929197
Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D PrintingNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT00229697
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyNo drug interventionstreatment2completed
NCT05826197
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT RadiomicsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02283983
Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative DoseNo drug interventionspreventionNot Availablecompleted
NCT00092183
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)prevention4completed
NCT01965483
Phase 2 Study of Adjuvant Radiotherapy in Breast Cancer Using a Once a Week Hypofractionated RegimenNo drug interventionstreatment2completed
NCT03678883
9-ING-41 in Patients With Advanced CancersNo drug interventionstreatment2active_not_recruiting
NCT00353483
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer CellsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04702061
Comparison of Erector Spina Plane Block and Thoracic Epidural BlockNo drug interventionstreatmentNot Availablecompleted
NCT01653561
A Study of Apatinib in Non-triple-negative Metastatic Breast CancerNo drug interventionstreatment2completed
NCT00475761
Breast Mammogram and Tissue StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00709761
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBCNo drug interventionstreatment2completed
NCT02583828
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00459628
Trial of Tomotherapy in Breast CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01325428
Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast CancerNo drug interventionstreatment2completed
NCT00320411
GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast CancerNo drug interventionstreatment2completed
NCT03979911
Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000611
Women's Health Initiative (WHI)prevention3completed
NCT01160211
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast CancerNo drug interventionstreatment3completed
NCT00050011
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapyprevention3completed
NCT03814811
Circulating Osteocalcin-positive Cells in Breast Cancer Bone MetastasisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00356811
Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast CancerNo drug interventionstreatment2completed
NCT00722293
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00001493
Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerNo drug interventionstreatment2completed
NCT02063893
Safety Study of Cancer Stem Cell Vaccinie to Treat Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02608593
Breast Reconstruction Outcomes With and Without StratticENo drug interventionsNot AvailableNot Availablecompleted
NCT00083993
Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancertreatment3terminated
NCT01088893
Everolimus in Breast Cancer Patients After Pre-operative ChemotherapyNo drug interventionstreatment2unknown_status
NCT00039793
Massage Therapy for Cancer-Related FatigueNo drug interventionstreatment2completed
NCT00046371
Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer PatientsNo drug interventionstreatment2completed
NCT00367471
Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.No drug interventionstreatment1completed
NCT00246571
Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancertreatment2completed
NCT01649271
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.No drug interventionstreatment1completed
NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00001378
A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancertreatment1completed
NCT03664778
Abbreviated Breast MRI After Cancer TreatmentNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00371488
GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast CancerNo drug interventionstreatment1completed
NCT01498588
Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerNo drug interventionstreatment2terminated
NCT03314688
Lifestyle, Exercise, and Nutrition Study Early After DiagnosisNo drug interventionsotherNot Availableactive_not_recruiting
NCT00784888
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02353988
AR-inhibitor Bicalutamide in Treating Patients With TNBCNo drug interventionstreatment2unknown_status
NCT06318507
The Intestinal Microbiome in Triple Negative Breast Cancer Treated With ImmunotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04297007
Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT02489409
Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast CancerNo drug interventionstreatment2unknown_status
NCT04965909
Pain Neuroscience Education and Graded Exposure to Movement in Breast Cancer SurvivorsNo drug interventionstreatmentNot Availablerecruiting
NCT00037609
Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patientstreatment1 / 2completed
NCT04059809
Photobiomodulation for Breast Cancer RadiodermatitisNo drug interventionsprevention2 / 3completed
NCT04916509
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf RegionNo drug interventionsNot AvailableNot Availablecompleted
NCT04603209
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05479409
Neoadjuvant Radiation in Locally Advanced Breast CancerNo drug interventionstreatment2recruiting
NCT00462956
GW572016 In Patients With Advanced Or Metastatic Breast CancerNo drug interventionstreatment1completed
NCT02423356
Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing DoxorubicinNo drug interventionsNot AvailableNot Availablecompleted
NCT00320385
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast CancerNo drug interventionstreatment3completed
NCT02860585
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00263185
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Statussupportive_care0completed
NCT00415285
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast CancerNo drug interventionstreatment2unknown_status
NCT00001385
Positron Emission Tomography in Patients With Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00417885
A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast CancerNo drug interventionstreatment1 / 2terminated
NCT02869815
ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01394315
Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast CancerNo drug interventionsNot AvailableNot Availableterminated
NCT06069115
Radiotherapy Exposed Lung Injury: Effect on Functioning - CohortNo drug interventionsNot AvailableNot Availablerecruiting
NCT02942615
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.No drug interventionsscreeningNot Availableactive_not_recruiting
NCT00926315
Gene Expression Profile of Breast Cancer Samples After Vitamin D SupplementationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04931615
ARTISS a Single-centre Randomised Control StudyNo drug interventionstreatment4completed
NCT01684215
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerNo drug interventionstreatment2completed
NCT00649337
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost ComparisonsNo drug interventionsscreeningNot Availableunknown_status
NCT01686737
Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer PatientsNo drug interventionstreatmentNot Availablewithdrawn
NCT02403037
Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03660137
Magnetic Occult Lesion Localization and Imaging (MOLLI)No drug interventionstreatmentNot Availablecompleted
NCT04241237
Concordance Between Liquid and Tissue BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02661932
Fertility Preservation in Breast Cancer PatientsNo drug interventionsprevention4unknown_status
NCT00072852
Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabinetreatment2completed
NCT00191152
A Phase III Trial For Patients With Metastatic Breast Cancertreatment3completed
NCT00041652
Safety Study of hMN14 to Treat Either Colorectal or Breast Cancertreatment1 / 2completed
NCT00375752
Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast CancerNo drug interventionstreatment4terminated
NCT05309252
The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa ProjectNo drug interventionsNot AvailableNot Availablecompleted
NCT01856452
Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast CancerNo drug interventionstreatment2completed
NCT01251900
BRCA Mutations in LatinasNo drug interventionsNot AvailableNot Availablecompleted
NCT01427400
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionNo drug interventionstreatment4unknown_status
NCT00101400
BAY43-9006 - Phase II in Advanced Breast Cancertreatment2completed
NCT05510700
Efficacy of Acupuncture Treatment for Breast Cancer-associated InsomniaNo drug interventionstreatmentNot Availablerecruiting
NCT00438100
Capecitabine vs. S-1 in Unresectable or Recurrent Breast CancerNo drug interventionstreatment2completed
NCT02228200
Nurse-led Care Program for Cancer Patients in Chemotherapy Day CenterNo drug interventionssupportive_careNot Availablecompleted
NCT03099200
An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00078000
A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.treatment2completed
NCT02145559
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00776659
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With AromasinNo drug interventionsNot AvailableNot Availableterminated
NCT00437359
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerNo drug interventionstreatment2terminated
NCT01942759
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06539559
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast CancerNo drug interventionstreatment2not_yet_recruiting
NCT02781259
Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast CancerNo drug interventionsdiagnostic4unknown_status
NCT00324259
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast CancerNo drug interventionstreatment2completed
NCT04608175
The Efficacy of Acupuncture as a Complementary Treatment for Pain and Anxiety After Breast Cancer SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT01945775
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)No drug interventionstreatment3completed
NCT01461070
Intestine Bacteria and Breast Cancer RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT00036270
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestanetreatment3completed
NCT03255070
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)No drug interventionstreatment1completed
NCT01866670
Effect of the Nursing Intervention "Spiritual Support"No drug interventionssupportive_care2unknown_status
NCT02612870
Sienna+® Injection Time Study 4 ArmsNo drug interventionsdiagnostic4unknown_status
NCT00001270
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and LymphomaNo drug interventionstreatment1completed
NCT00950742
Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer.No drug interventionstreatment1completed
NCT00247442
Australian Screening Mammography Decision Aid Trial (ASMDAT)No drug interventionseducational_counseling_trainingNot Availablecompleted
NCT03698942
Delphinus SoftVue™ ROC Reader StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02213042
Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT00525642
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast CancerNo drug interventionstreatment2 / 3unknown_status
NCT02480842
Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate ReconstructionNo drug interventionstreatmentNot Availablecompleted
NCT02938442
Vaccination of Triple Negative Breast Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT02600442
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersNo drug interventionsNot AvailableNot Availableunknown_status
NCT05452499
Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With SequelaeNo drug interventionstreatmentNot Availablecompleted
NCT02389699
Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in SituNo drug interventionstreatmentNot Availableunknown_status
NCT00123799
Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary DissectionNo drug interventionsdiagnostic2terminated
NCT00429299
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerNo drug interventionstreatment2completed
NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studYNo drug interventionstreatment3active_not_recruiting
NCT02374099
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With FulvestrantNo drug interventionstreatment2terminated
NCT05068999
Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00089999
Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancertreatment2completed
NCT02003599
Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation TherapyNo drug interventionspreventionNot Availablecompleted
NCT00307606
Does a Single Steroid Injection Reduce the Formation of Postmastectomy SeromaNo drug interventionstreatment4unknown_status
NCT04816006
Breast Cancer, Reasoning, and Activity InterventionNo drug interventionssupportive_careNot Availablerecruiting
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT06105749
Biennial CEM in Women With a Personal History of Breast CancerNo drug interventionsscreeningNot Availablerecruiting
NCT02229149
Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast CancerNo drug interventionstreatment2terminated
NCT00288249
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancertreatment2completed
NCT01713049
18F-FLT PET for Suspicious Findings on Mammography and Breast UltrasoundNo drug interventionsdiagnosticNot Availableunknown_status
NCT00146536
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT03659136
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has SpreadNo drug interventionstreatment2completed
NCT01178736
Early Detection of Cancers in Low Resource CountriesNo drug interventionsNot AvailableNot Availableunknown_status
NCT06259513
Omission of Axillary Surgery in Breast Cancer PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT05339113
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast CarcinomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT02627313
Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)No drug interventionstreatmentNot Availableunknown_status
NCT00373113
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And CapecitabineNo drug interventionstreatment3terminated
NCT01730118
Ad/HER2/Neu Dendritic Cell Cancer Vaccine TestingNo drug interventionstreatment1completed
NCT02187718
Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - TrialNo drug interventionsdiagnosticNot Availableunknown_status
NCT06490718
Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer SurgeryNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06133218
Patient Reported Outcomes Using Mepitel Film During RadiotherapyNo drug interventionspreventionNot Availablecompleted
NCT04852419
A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTSNo drug interventionstreatment1completed
NCT01845519
Step by Step: A Tailored Walking Intervention for Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT00347919
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerNo drug interventionstreatment2completed
NCT03477019
Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerNo drug interventionstreatment1 / 2completed
NCT02946619
Health Benefits of Expressive Writing Among Chinese Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT05764941
Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00607841
A Study of Ispinesib in Metastatic Breast CancerNo drug interventionstreatment1terminated
NCT01272141
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast CancerNo drug interventionstreatment2terminated
NCT04108117
Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate ReconstructionNo drug interventionsNot AvailableNot Availablecompleted
NCT01205217
Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast CancerNo drug interventionstreatment2withdrawn
NCT00179634
Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast CancerNo drug interventionstreatmentNot Availableterminated
NCT00174434
Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancertreatment1completed
NCT03092934
A Study of AK-01 (LY3295668) in Solid TumorsNo drug interventionstreatment1 / 2completed
NCT03709134
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00494234
Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast CancerNo drug interventionstreatment2completed
NCT02530424
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "No drug interventionsother2completed
NCT04718324
PREMs on PROMs in Breast Disease (PREMs_PROMs)No drug interventionshealth_services_research3completed
NCT02449824
MRI and Early Decision-making in Chemotherapy for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02596724
TME Neoadjuvant Breast RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT06468124
Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer MetastasesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00207324
The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin ReactionsNo drug interventionsprevention3completed
NCT02603016
Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast CarcinomaNo drug interventionssupportive_careNot Availablecompleted
NCT03242616
PemVin vs Vin in Previously Treated Metastatic Breast CancerNo drug interventionstreatment2unknown_status
NCT04554316
Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast SurgeryNo drug interventionssupportive_careNot Availablecompleted
NCT01176916
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In ChinaNo drug interventionsNot Available4completed
NCT01446016
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)No drug interventionstreatment2completed
NCT02034916
A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)No drug interventionstreatment2terminated
NCT01026116
A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years OldNo drug interventionstreatment3completed
NCT00355316
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer PatientsNo drug interventionsbasic_scienceNot Availablecompleted
NCT06322316
Analgesic Efficacy of U/S Retrolaminar Block and Erector Spinae Plane Block in MRMNo drug interventionssupportive_careNot Availablecompleted
NCT00092196
Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)prevention3completed
NCT06551896
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid TumorNo drug interventionstreatment2not_yet_recruiting
NCT01605396
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)No drug interventionstreatment2completed
NCT02306096
Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03594396
Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast CancerNo drug interventionstreatment1 / 2unknown_status
NCT00281658
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2treatment3completed
NCT02378558
A Trial of a New Magnetic Breast Marking ClipNo drug interventionstreatmentNot Availableterminated
NCT00341458
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsNo drug interventionsNot AvailableNot Availablecompleted
NCT00553358
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyNo drug interventionstreatment3completed
NCT00445458
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerNo drug interventionstreatment1 / 2completed
NCT02620735
Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:ProtocolNo drug interventionssupportive_careNot Availablecompleted
NCT00141635
Implementation of Quality of Life Diagnostics and TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02541435
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00798135
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT02638935
Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 LesionsNo drug interventionsdiagnosticNot Availablecompleted
NCT03596463
Influence of Multidisciplinary Breast Tumor Board on Physician DecisionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05743686
App for Adverse Events to Oral Chemotherapy - Pilot StudyNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT02476786
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreNo drug interventionstreatment2recruiting
NCT05774886
Implantable Microdevice for TNBC - Pilot StudyNo drug interventionstreatment1withdrawn
NCT00858039
Cardiotoxicity of Adjuvant TrastuzumabNo drug interventionsNot AvailableNot Availablecompleted
NCT00001239
Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast CancerNo drug interventionstreatment2completed
NCT02141139
Perioperative Inflammation and Breast Cancer OutcomeNo drug interventionstreatment3unknown_status
NCT00120939
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancertreatment1completed
NCT01231022
Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)No drug interventionsNot AvailableNot Availablecompleted
NCT00034125
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.treatment3completed
NCT01887925
The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT04528225
A Prospective Study of Hypothyroidism After Radiotherapy for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02835625
The Digital Breast Tomosynthesis Trial in BergenNo drug interventionsdiagnosticNot Availablecompleted
NCT00079625
Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast CancerNo drug interventionstreatment1completed
NCT00044525
Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patientstreatment2completed
NCT01271725
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresNo drug interventionstreatment2completed
NCT00446030
Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast CancerNo drug interventionstreatment2completed
NCT02510430
The Plan and Stand Study: Reducing Sitting Time in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00527930
Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerNo drug interventionstreatment2completed
NCT05904730
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 MutationsNo drug interventionstreatment1enrolling_by_invitation
NCT05711030
Thoracic Paravertebral Block Anesthesia for Breast Cancer SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT01479348
Imaging Study for FdCyd and THU Cancer TreatmentNo drug interventionsdiagnostic0terminated
NCT02865148
Behavioral Symptom Management Program for Breast Cancer in Singapore and The USNo drug interventionssupportive_careNot Availablecompleted
NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNo drug interventionsNot AvailableNot Availableterminated
NCT02115048
Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole AloneNo drug interventionstreatment2terminated
NCT02489448
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast CancerNo drug interventionstreatment1 / 2completed
NCT00321048
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABCNo drug interventionstreatmentNot Availablecompleted
NCT01198457
Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT06319157
Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast ReconstructionNo drug interventionstreatmentNot Availablerecruiting
NCT04522557
Type I Interferon Alfa-2a in Postmastectomy Breast ReconstructionNo drug interventionstreatment1completed
NCT04608357
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02491957
Impact of LOFT Therapy™ on Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03374826
PET-MRI for Axillary Staging in Node Negative Breast Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT01695226
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast CancerNo drug interventionstreatment2completed
NCT02485626
Identifying Subgroups With High Cardiovascular Risk in Breast Cancer SurvivorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00058526
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancertreatment1completed
NCT01662726
A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer GrowthNo drug interventionstreatment2terminated
NCT03705026
Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT05485766
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerNo drug interventionstreatment2recruiting
NCT02303366
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475No drug interventionstreatment1completed
NCT00127465
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsNo drug interventionsNot Available1 / 2completed
NCT00932165
Special Investigation For Patients With Renal And/Or Hepatic Disorders On AromasinNo drug interventionsNot AvailableNot Availablecompleted
NCT02278965
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast CancerNo drug interventionstreatment1completed
NCT01437865
Gadofosveset for Axillary Staging in Breast Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT02895165
PREgnancy and FERtility RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01262274
Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerNo drug interventionstreatment2terminated
NCT02463474
Mobile Health (mHealth) Black Women With Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00899574
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin MetastasesNo drug interventionstreatment2completed
NCT01396174
A Novel Prosocial Online Support Group for Distressed Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02076074
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT01723774
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT01582074
The Ultrasound Study of TamoxifenNo drug interventionsNot AvailableNot Availablecompleted
NCT05578820
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidNo drug interventionstreatment1completed
NCT04918082
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in MartiniqueNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06530082
A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast CancerNo drug interventionstreatment1not_yet_recruiting
NCT00310882
Involvement of Endogenous Digitalis-like Compounds in Breast CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02254031
Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast CancerNo drug interventionstreatment1terminated
NCT06235931
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBCNo drug interventionstreatmentNot Availablerecruiting
NCT04373031
Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT00027131
Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70No drug interventionstreatment1 / 2terminated
NCT00073073
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancerprevention2completed
NCT03904173
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03744273
Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03528473
Adapted Physical Activity (APA) in a Breast Cancer Population.No drug interventionstreatmentNot Availableunknown_status
NCT00830973
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00089973
Study Of Ispinesib In Subjects With Breast Cancertreatment2completed
NCT00191373
A Trial for HER2 Positive Breast Cancer Patients With Metastatic Diseasetreatment2completed
NCT01265927
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast CancerNo drug interventionstreatment1completed
NCT02395627
Reversing Therapy Resistance With Epigenetic-Immune ModificationNo drug interventionstreatment2terminated
NCT02416427
Targeting the Hippo Transducer TAZ in Breast Cancer With StatinsNo drug interventionstreatment2unknown_status
NCT01740427
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)No drug interventionstreatment3completed
NCT00034827
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancertreatment2completed
NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)No drug interventionstreatment3recruiting
NCT05463276
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01140776
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT01499160
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast CancerNo drug interventionstreatment2terminated
NCT02411760
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT02934360
TR(ACE) Assay Clinical Specimen StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04769960
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After MastectomyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04685460
3D Printed Bolus in Post-mastectomy RadiotherapyNo drug interventionstreatmentNot Availableunknown_status
NCT02732860
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostNo drug interventionsNot AvailableNot Availablerecruiting
NCT04932460
Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT04990960
Experimental Study About Physiotherapy Treatment vs Self-treatment In Axillary Web Syndrome After Axillary DissectionNo drug interventionstreatmentNot Availablecompleted
NCT02627560
The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing MastectomyNo drug interventionsprevention4completed
NCT02406794
Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer SurvivorsNo drug interventionstreatment1 / 2completed
NCT00005494
Prospective Study of Health in Runners and WalkersNo drug interventionsNot AvailableNot Availablecompleted
NCT02834494
Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave),No drug interventionsotherNot Availablecompleted
NCT02866994
Project Connect Online: An Internet-based Intervention for Women With Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02340494
An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT01137994
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast CancerNo drug interventionstreatment2withdrawn
NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT00996762
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of LapatinibNo drug interventionstreatment1completed
NCT01232062
Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05263362
An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00522262
Alberta Physical Activity and Breast Cancer Prevention (ALPHA) TrialNo drug interventionspreventionNot Availablecompleted
NCT00499980
Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer DiagnosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03500380
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesNo drug interventionstreatment2 / 3active_not_recruiting
NCT00284180
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancertreatment2completed
NCT03435380
Promoting Breast Cancer Screening in Women Who Survived Childhood CancerNo drug interventionspreventionNot Availablecompleted
NCT00039780
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelNo drug interventionstreatment3completed
NCT03583580
Accelerated Partial Breast Irradiation With IMRT in Early Breast CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01849380
Neoadjuvant ECS Versus ECF in Local Advanced Breast CancerNo drug interventionstreatment4unknown_status
NCT04799080
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT01247129
Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood FlowNo drug interventionstreatment2completed
NCT00399529
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast CancerNo drug interventionstreatment2completed
NCT04386629
Health Economy RegisterNo drug interventionsNot AvailableNot Availablecompleted
NCT04341129
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)No drug interventionsdiagnostic0completed
NCT00034489
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.treatment2completed
NCT01169792
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06157892
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT04930692
A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"No drug interventionsdiagnosticNot Availableunknown_status
NCT02718144
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast CancerNo drug interventionsother1 / 2completed
NCT02771444
Low Dose Tomosynthesis Compared to Traditional TomosynthesisNo drug interventionsdiagnosticNot Availableterminated
NCT00418444
Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?No drug interventionsNot AvailableNot Availablecompleted
NCT02806544
Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income CountryNo drug interventionstreatment2completed
NCT02701244
A Registry Study of Breast Microseed TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT02922244
Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer PatientsNo drug interventionspreventionNot Availablecompleted
NCT06224244
External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer PatientsNo drug interventionstreatment2recruiting
NCT05584644
A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01368744
Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section HistopathologyNo drug interventionsNot AvailableNot Availablecompleted
NCT00370240
Chlorhydrate of Ropivacaine and Breast Cancer SurgeryNo drug interventionstreatment4completed
NCT00272740
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancertreatment2completed
NCT04890340
In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00826267
6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or TrastuzumabNo drug interventionstreatment2completed
NCT00892567
Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast CancerNo drug interventionstreatment1completed
NCT01256801
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionNo drug interventionsNot AvailableNot Availablecompleted
NCT00934401
Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01198301
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02181101
Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-TrialNo drug interventionstreatment3completed
NCT04881604
Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related LymphedemaNo drug interventionstreatmentNot Availablecompleted
NCT02276404
Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00188604
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancertreatment2completed
NCT03389204
Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy InterventionNo drug interventionssupportive_careNot Availablecompleted
NCT02338804
Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma PatientNo drug interventionstreatment1 / 2completed
NCT00869804
Heading Off Peripheral Neuropathy With ExerciseNo drug interventionssupportive_careNot Availableterminated
NCT00849472
Treatment With Pazopanib for Neoadjuvant Breast CancerNo drug interventionstreatment2completed
NCT05067972
A Study of PF-07260437 in Advanced or Metastatic Solid TumorsNo drug interventionstreatment1terminated
NCT00191672
A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancertreatment2completed
NCT00416572
Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01357772
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upNo drug interventionsprevention3active_not_recruiting
NCT04200768
FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.No drug interventionsbasic_scienceNot Availablerecruiting
NCT00001468
Outcomes of Education and Counseling for BRCA1 TestingNo drug interventionsNot AvailableNot Availablecompleted
NCT01821768
Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation TherapyNo drug interventionsdiagnosticNot Availableterminated
NCT00604968
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)No drug interventionstreatment4terminated
NCT02467868
Efficacy and Safety Study With MYL-1401H and NeulastaNo drug interventionstreatment3completed
NCT01891669
A Study Of PF-06263507 In Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT01731769
Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted ClosureNo drug interventionspreventionNot Availableunknown_status
NCT00188669
The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Paintreatment2terminated
NCT01136369
Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00123669
Primary Progesterone Therapy for Operable Breast CancerNo drug interventionstreatment2 / 3completed
NCT06335069
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.No drug interventionsdiagnostic2not_yet_recruiting
NCT00001269
Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast CancerNo drug interventionstreatment1completed
NCT01420146
Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer PatientsNo drug interventionsdiagnostic1completed
NCT02818946
Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective TrialNo drug interventionsdiagnosticNot Availableterminated
NCT01138046
Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBCNo drug interventionstreatment2completed
NCT03130946
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph NodesNo drug interventionsdiagnosticNot Availablesuspended
NCT06266312
Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With BreastcancerNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT04629612
Regional Anesthesia in Breast SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT02584712
Effect of Exercise Training in Autonomic Modulation in Breast Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02707510
A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04085510
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western PennsylvaniaNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT02510781
A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCsNo drug interventionstreatment2unknown_status
NCT00300781
Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancertreatment2completed
NCT01236781
Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back RatesNo drug interventionsscreening2 / 3unknown_status
NCT02771795
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BCNo drug interventionsNot AvailableNot Availableterminated
NCT00110695
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancertreatment2completed
NCT05326295
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04572295
A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast CancerNo drug interventionstreatment1active_not_recruiting
NCT03273595
Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast CancerNo drug interventionstreatment2unknown_status
NCT04993014
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast CancerNo drug interventionstreatment2recruiting
NCT04627714
Adapted Fencing in Breast Cancer: a Pilot StudyNo drug interventionssupportive_careNot Availableunknown_status
NCT00040014
Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Womentreatment2terminated
NCT00138814
Boost Use in Breast Conservation RadiotherapyNo drug interventionstreatment3unknown_status
NCT05981014
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast CancerNo drug interventionstreatment1 / 2recruiting
NCT04915755
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular DiseaseNo drug interventionstreatment3active_not_recruiting
NCT00174655
BIG 02/98 Docetaxel - Breast Cancertreatment3completed
NCT06509555
Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04719455
Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET)No drug interventionssupportive_careNot Availableunknown_status
NCT04596150
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast CancerNo drug interventionstreatment2completed
NCT04752150
ESPB and RIB for Pain Management Following Mastectomy SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT00092950
Exercise in Women at Risk for Breast CancerNo drug interventionstreatment2completed
NCT06187350
The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region ÖstergötlandNo drug interventionsNot AvailableNot Availablerecruiting
NCT01779050
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor CellsNo drug interventionstreatment2terminated
NCT05673850
Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01550250
Night-time Compression Systems for Breast Cancer Related LymphedemaNo drug interventionssupportive_careNot Availablecompleted
NCT03749850
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerNo drug interventionstreatment1unknown_status
NCT00147550
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.treatment1 / 2terminated
NCT00978250
A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)No drug interventionstreatment2completed
NCT01908023
Exercise and Radiotherapy, a Good Combination?No drug interventionstreatmentNot Availablecompleted
NCT02521623
SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized TrialNo drug interventionstreatmentNot Availablecompleted
NCT01661023
The Ghana Breast Health StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03284723
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsNo drug interventionstreatment1terminated
NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast CancerNo drug interventionstreatment1 / 2recruiting
NCT02658708
Bright Light on Fatigue in Women Being Treated for Breast CancerNo drug interventionstreatment1completed
NCT05141708
Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2mNo drug interventionsNot AvailableNot Availablecompleted
NCT01194908
Re-expression of ER in Triple Negative Breast CancersNo drug interventionstreatment1 / 2terminated
NCT00041808
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Livertreatment1 / 2completed
NCT00140738
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast CancerNo drug interventionsprevention1completed
NCT02306538
Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRINo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00191438
Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agentstreatment3completed
NCT01572038
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerNo drug interventionstreatment3completed
NCT01271738
Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT01547338
Photography or Video in Assessing Breast Reconstruction?No drug interventionsNot AvailableNot Availablecompleted
NCT04676438
Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk FactorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00405938
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast CancerNo drug interventionstreatment2completed
NCT02774473
[18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel TherapydiagnosticNot Availablerecruiting
NCT04277468
Assessing an Oral SERD, DZD3969 in Patients With Advanced ER+HER2- Breast Cancer (MU-LAN1)No drug interventionstreatment1 / 2not_yet_recruiting
NCT05050890
Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast NeoplasiaNo drug interventionsNot AvailableNot Availableunknown_status
NCT04767464
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual GroupsNo drug interventionssupportive_careNot Availablecompleted
NCT03756064
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04893421
Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion LocalizationNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03651921
Testing of the Cancer Thriving and Surviving Breast Cancer ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT04388384
Real-life Pan-HER-blockade With NeratinibNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04002284
Anlotinib in Metastatic HER2 Negative Breast CancerNo drug interventionstreatment2completed
NCT00591747
Strength Training for Older Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00001898
Microarray Analysis for Human Genetic DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03874598
Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT02372305
Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive SurgeryNo drug interventionstreatment4withdrawn
NCT05949983
Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT02316561
Single Dose Ablative Radiation Treatment for Early-Stage Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT03740893
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancerother2recruiting
NCT03220178
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapytreatment4terminated
NCT00001507
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast CancerNo drug interventionstreatment1completed
NCT04652609
Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise ProgramNo drug interventionspreventionNot Availablerecruiting
NCT00779285
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)No drug interventionstreatment4terminated
NCT02061085
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatmenttreatment2completed
NCT02318615
Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema PreventionNo drug interventionspreventionNot Availableunknown_status
NCT03141437
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT00001837
Effects of Raloxifene on the Uterus and Ovaries of Premenopausal PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03021200
Laser Fluorescence in Cancer Surgical TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT01061359
Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast CancerNot AvailableNot Availablecompleted
NCT02950259
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)treatment1active_not_recruiting
NCT03351075
Effectiveness of a Modern Educational Intervention in Breast Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01221870
Tesetaxel as First-line Therapy for Metastatic Breast Cancertreatment2unknown_status
NCT03069742
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care SettingNo drug interventionspreventionNot Availablecompleted
NCT05582499
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapytreatment2recruiting
NCT00659906
Optimizing Body Composition & Health After Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04305236
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancertreatment2terminated
NCT01859936
Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary TreatmentNo drug interventionsdiagnostic4completed
NCT03280836
Exercise Program in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT02284919
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancerdiagnostic1active_not_recruiting
NCT03330717
Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT02800317
RISAS Procedure in Node Positive Breast Cancer Following NACNo drug interventionsdiagnosticNot Availablecompleted
NCT02609724
Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRLNo drug interventionstreatmentNot Availablecompleted
NCT04583124
Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)No drug interventionstreatmentNot Availablerecruiting
NCT03368196
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Proteintreatment1completed
NCT00201435
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BCtreatment2 / 3completed
NCT03024463
The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00583739
Yoga to Reduce Cancer FatigueNo drug interventionssupportive_care2completed
NCT01755130
Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast CancerNo drug interventionsdiagnosticNot Availableterminated
NCT00313248
Evaluation of a New Agent for Treatment of Advanced Stage Breast CancerNo drug interventionstreatment2completed
NCT03328026
Combination Study of SV-BR-1-GM With Retifanlimabtreatment1 / 2enrolling_by_invitation
NCT03273426
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.No drug interventionsdiagnosticNot Availablecompleted
NCT05309265
Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility StudyNo drug interventionsotherNot Availableactive_not_recruiting
NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNo drug interventionstreatment2recruiting
NCT06294574
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon SatisfactionNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04861220
Surgical Pre-habilitation in Breast Cancer.No drug interventionspreventionNot Availableunknown_status
NCT02610920
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injectiondiagnostic0withdrawn
NCT02370082
SAVI SCOUT Clinical Evaluation StudyNo drug interventionstreatmentNot Availableunknown_status
NCT02970682
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancertreatment2completed
NCT02992782
Decongestive Exercise and Compression for Breast Cancer Related Lymphedema ManagementNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03546673
Health Benefits of Expressive Writing: Study OneNo drug interventionssupportive_careNot Availablecompleted
NCT02913573
Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstructiontreatment2unknown_status
NCT04083027
Non-mass Enhancement in Breast MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT03275727
A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast CancerNo drug interventionssupportive_care2 / 3unknown_status
NCT05512260
Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening ProgramsNo drug interventionsscreeningNot Availablerecruiting
NCT02065960
Feasibility Study of Stereotactic Body Radiotherapy for Early Breast CancerNo drug interventionstreatment1unknown_status
NCT05020860
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancertreatment2recruiting
NCT00270894
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patientstreatment2completed
NCT05633680
Circulating Tumor Cells Screen for Breast CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03024580
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancertreatment2unknown_status
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumorstreatment1active_not_recruiting
NCT04678544
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer PatientsNo drug interventionspreventionNot Availablecompleted
NCT06212440
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant ChemotherapyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02602067
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsNo drug interventionstreatment1terminated
NCT00249301
A Study of MLN8054 in Patients With Advanced Solid Tumorstreatment1terminated
NCT00001504
A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patientstreatment1completed
NCT01466972
Reversing Hormone Resistance in Advanced Breast Cancer With PazopanibNo drug interventionstreatment2completed
NCT02561468
The Preemptive Analgesic Efficacy of NefopamNo drug interventionspreventionNot Availablecompleted
NCT06100068
HOBBIT 3: Mental Exercises and Temporal AlterationNo drug interventionstreatmentNot Availablecompleted
NCT05033769
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast CancerNo drug interventionstreatment4unknown_status
NCT03269981
Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00034281
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2treatment1completed
NCT03013881
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy VolunteersNo drug interventionstreatment1completed
NCT01621295
Assessing the Patient Experience in Cancer CareNo drug interventionsNot AvailableNot Availablecompleted
NCT05594095
SNF Platform Study of HR+/ HER2-advanced Breast CancerNo drug interventionstreatment2recruiting
NCT03124095
Combined Training Intervention for Women Who Underwent Primary Treatment for Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT06337214
TCM Therapy Program Impact on Breast Cancer Patients' Vital EnergyNo drug interventionssupportive_careNot Availablerecruiting
NCT06058650
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast AbnormalitiesNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005908
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancertreatment2completed
NCT05441943
Lymphaticovenous Anastomosis as Treatment for LymphedemaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03321903
EPR Tumor Oximetry With CE India InkNo drug interventionsNot AvailableNot Availableterminated
NCT01707121
The Impact of Physical Activity on the Outcome of SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT01015521
Efficacy Study of Aminoflavone Prodrug to Treat Breast CancerNo drug interventionstreatment2withdrawn
NCT01432002
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03740984
Effects of Music or Hypnotherapy on Cancer Patients During ChemotherapyNo drug interventionssupportive_careNot Availableterminated
NCT04109079
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT05868187
CanRestoreFunction Cancer-related Fatigue ( CRF )No drug interventionstreatmentNot Availablerecruiting
NCT00736333
A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)No drug interventionsNot AvailableNot Availablecompleted
NCT03426254
Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid TumorsNo drug interventionstreatment1withdrawn
NCT05851053
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00194753
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12treatment2completed
NCT05604677
Factor Influencing Breast Surgery Type Decision-MakingNo drug interventionsNot AvailableNot Availablecompleted
NCT01233947
Study of AFP464 +/- Faslodex in ER + Breast CancerNo drug interventionstreatment2terminated
NCT03066947
SV-BR-1-GM in Metastatic or Locally Recurrent Breast CancerNo drug interventionstreatment1 / 2completed
NCT06090747
Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.No drug interventionstreatmentNot Availablerecruiting
NCT00831545
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)No drug interventionstreatment2completed
NCT05576545
Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing TreatmentNo drug interventionsotherNot Availablecompleted
NCT01758445
Proton Radiation for Stage II/III Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT03939598
Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03881605
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBCNo drug interventionsscreeningNot Availableunknown_status
NCT02914197
Giving Information on the Risks and Limitations of Mammography Screening (GIRLS)No drug interventionshealth_services_researchNot Availableunknown_status
NCT01766297
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerNo drug interventionstreatment2recruiting
NCT01199393
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05267171
Project Breast47: Effect of an Educational InterventionNo drug interventionspreventionNot Availablecompleted
NCT00550771
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)No drug interventionstreatment2completed
NCT05427071
Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant ChemotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT02983071
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerNo drug interventionstreatment1 / 2active_not_recruiting
NCT00463788
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast CancerNo drug interventionstreatment2completed
NCT05889988
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00821288
Post-treatment Care of Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03445637
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®No drug interventionsNot AvailableNot Availablerecruiting
NCT03295552
Decitabine Plus Carboplatin in the Treatment of Metastatic TNBCNo drug interventionstreatment2terminated
NCT03455270
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast CancerNo drug interventionstreatment1completed
NCT04824599
Regional Anesthesia and Partial MastectomyNo drug interventionspreventionNot Availablecompleted
NCT03687749
Presentation of First Time Attenders at Lymphedema ClinicsNo drug interventionsNot AvailableNot Availablecompleted
NCT04227613
Aspects of Breast-conserving SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02432118
Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing LumpectomyNo drug interventionsdiagnosticNot Availablewithdrawn
NCT02455141
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast CancerNo drug interventionstreatment3unknown_status
NCT05507034
Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.No drug interventionsNot AvailableNot Availablerecruiting
NCT02978716
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)No drug interventionstreatment2terminated
NCT02608216
[18F]FLT PET/CT in Rb+ Metastatic Breast CancerNo drug interventionsdiagnostic1active_not_recruiting
NCT00107016
Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Womentreatment2completed
NCT02409316
[18F]FES PET/CT in Endocrine Refractory Breast CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT00001496
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04799535
Quantitative Microvasculature Imaging for Breast Cancer Detection and MonitoringNo drug interventionsNot AvailableNot Availablerecruiting
NCT03625635
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic TreatmentNo drug interventionssupportive_careNot Availableunknown_status
NCT00638963
Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)No drug interventionsprevention2terminated
NCT03715686
To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph NodesNo drug interventionsdiagnosticNot Availableunknown_status
NCT01596530
Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin TreatmentNo drug interventionsbasic_science1terminated
NCT04644848
Ultrasonographic Axillary LocalizationNo drug interventionsdiagnosticNot Availableunknown_status
NCT03761420
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT04640220
Improvement of Range of Motion in Frozen Shoulder in Breast Cancer SurvivorsNo drug interventionstreatmentNot Availablecompleted
NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04444882
Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy CareNo drug interventionsNot AvailableNot Availablecompleted
NCT03008031
Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)No drug interventionsdiagnosticNot Availableterminated
NCT05465031
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)No drug interventionsprevention4not_yet_recruiting
NCT04489173
TAS102 in Patients With ER-positive, HER2-negative Advanced Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT00194727
Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancertreatment2completed
NCT02627976
Breast Edema Compression VestNo drug interventionstreatmentNot Availablecompleted
NCT03266562
Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission MammographyNo drug interventionsdiagnosticNot Availablewithdrawn
NCT02056080
Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or LapatinibNo drug interventionsNot AvailableNot Availablecompleted
NCT00295529
GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family PhysiciansNo drug interventionsNot AvailableNot Availablecompleted
NCT00779129
A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)No drug interventionstreatment2completed
NCT03000192
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeNo drug interventionsNot AvailableNot Availableunknown_status
NCT06251544
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNo drug interventionstreatment1not_yet_recruiting
NCT00687440
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)No drug interventionstreatment2completed
NCT00001440
Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapytreatment1completed
NCT00194740
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancertreatment2completed
NCT05169567
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerNo drug interventionstreatment3active_not_recruiting
NCT03202472
Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT02513472
Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC)No drug interventionstreatment1 / 2completed
NCT00530868
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast CancerNo drug interventionstreatment2completed
NCT03606369
Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.No drug interventionsprevention2 / 3unknown_status
NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.No drug interventionstreatment3recruiting
NCT06075810
A Study of Oral MBQ-167 in Participants With Advanced Breast CancerNo drug interventionstreatment1recruiting
NCT05862610
The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBCNo drug interventionstreatment2not_yet_recruiting
NCT00771381
A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast CancerNo drug interventionsdiagnostic2terminated
NCT02957981
The Genetic Education for Men Trial: Web-Based Education vs. Standard CareNo drug interventionssupportive_careNot Availablecompleted
NCT00251095
Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancertreatment3terminated
NCT00573495
Multipeptide Vaccine for Advanced Breast CancerNo drug interventionstreatment1completed
NCT04440995
The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast ReconstructionNo drug interventionspreventionNot Availablecompleted
NCT06056414
Study of Anxiety After a Session of Energy Resonance by Cutaneous StimulationNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03868514
Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)No drug interventionsNot AvailableNot Availablecompleted
NCT00005655
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancertreatment1terminated
NCT05364450
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT00001250
Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trialtreatment2completed
NCT06255808
Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorNo drug interventionsNot AvailableNot Availablerecruiting
NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)No drug interventionstreatment2recruiting
NCT05505643
Cryoablation vs Lumpectomy in T1 Breast CancersNo drug interventionstreatmentNot Availablerecruiting